Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm Metastasis × Acetaminophen × Clear all

Phase

Phase 1 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Lymphoma, Large B-Cell, Diffuse 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Trigger Finger Disorder 1 Sarcoma, Alveolar Soft Part 1 Renal Insufficiency 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Pain 1 Neoplasms, Plasma Cell 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Mucositis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Leukemia 1 Kidney Neoplasms 1 Infratentorial Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Diseases 1 Head and Neck Neoplasms 1

Interventions

Oxaliplatin 56 Capecitabine 55 Fluorouracil 51 Bevacizumab 49 Gemcitabine 44 Paclitaxel 43 Leucovorin 43 Carboplatin 36 Nivolumab 35 Irinotecan 33 Docetaxel 33 pembrolizumab 32 Cisplatin 30 Cetuximab 30 Radiosurgery 22 Trastuzumab 21 Cyclophosphamide 20 Sunitinib 19 Radiotherapy 18 Panitumumab 18 Doxorubicin 18 Interleukin-2 16 Pemetrexed 15 Fulvestrant 15 Everolimus 15 Drug Therapy 15 Ipilimumab 14 atezolizumab 13 Sorafenib 13 Albumin-Bound Paclitaxel 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00712712 2025-08-29

MEDOR

Institut Bergonié

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡